449 results on '"Belluardo,N."'
Search Results
2. Neurotrophic effects of central nicotinic receptor activation
3. Regulation of connexin gene expression during skeletal muscle regeneration in the adult rat
4. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms
5. Expression of the rat connexin 39 (rCx39) gene in myoblasts and myotubes in developing and regenerating skeletal muscles: an in situ hybridization study
6. GFAPβ mRNA Expression in the Normal Rat Brain and after Neuronal Injury
7. Expression of neurotrophins, GDNF, and their receptors in rat thyroid tissue
8. Sicilian Network for Inflammatory Bowel Disease (SN-IBD). A propensity score-matched comparison of infliximab and adalimumab in naïve and non-naïve patients with Crohn’s disease
9. OC.05.1 ROLE OF ARTIFICIAL INTELLIGENCE IN SMALL BOWEL CAPSULE ENDOSCOPY TRAINING
10. PC.01.2 DIAGNOSTIC ACCURACY OF CAPSULE ENDOSCOPY READING ASSISTED BY ARTIFICIAL INTELLIGENCE FOR EXPERT READERS: INTERIM ANALYSIS OF A SINGLE CENTER EXPERIENCE
11. The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy
12. The sicilian network of biological therapy in inflammatory bowel disease: preliminary data from a prospective study on efficacy and safety
13. The sicilian network for inflammatory bowel disease (SN-IBD): preliminary data on efficacy of biological therapy
14. OC.15.1: DIAGNOSTIC YIELD OF AI-ASSISTED CAPSULE ENDOSCOPY: AN INTERIM ANALYSIS OF COMPARISON BETWEEN EXPERTS AND TRAINEES.
15. Diagnostic yield of AI-assisted capsule endoscopy reading: an interim analysis of camparison between experts and trainees.
16. AF.57 SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
17. AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE
18. OC.12.1 SPOSIB SB2 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2
19. PC.01.2 A PROPENSITY SCORE WEIGHTED COMPARISON OF VEDOLIZUMAB AND ADALIMUMAB IN CROHN'S DISEASE: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)
20. No effect of low-intensity endurance exercise on muscle necrosis in the diaphragm of mdx mice
21. Effects of mild aerobic exercise training on the diaphragm in mdx mice
22. P.07.1 ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) ARE LESS LIKELY TO PERSIST ON ANTI-TNF THERAPY COMPARED WITH YOUNGER PATIENTS. DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD)
23. P.02.4 EFFECTIVENESS OF VEDOLIZUMAB ON INTESTINAL AND ARTICULAR OUTCOMES: REAL-WORLD DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)
24. OC.02.4 THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): A COMPARISON OF THE EFFICACY OF CURRENT BIOLOGICS IN CROHN'S DISEASE
25. Effect of trophic factors, released after hippocampal injury, on astroglial cell proliferation
26. Complications de la polypectomie endoscopique gastrique et duodénale expérience italienne
27. Early and late complications of endoscopic oesophageal varices sclerotherapy
28. Suivi endoscopique après sclérothérapie élective pour varices œsophagiennes: résultats de deux schémas de surveillance différents
29. Can guanine-based purines be considered modulators of intestinal motility in rodents?
30. Gene expression and localization of glutamate receptor NR3b in central nervous system
31. Membrane domains in CNS physiology and pathology. Abstracts of the Fourth International Society for Neurochemistry (ISN) Special Conference. Erice (Trapani), Sicily, Italy, 22-26 May 2010
32. Pharmacological activation of group-II mGlu receptors enhances the formation of glial-derived neurotrophic factor (GDNF) in the mouse corpus striatum
33. Antiproliferative effects of guanine-based purines and identification of a candidate receptor
34. Distinct pattern of Connexin gene expression during skeletal muscle regeneration in the adult rat
35. Antiproliferative Effects Of Guanine-Based Purines And Espression Of A Candidate Receptor
36. Neuroprotection by group-II metabotropic glutamate receptor agonists requires the presence of mGlu3 receptors and is mediated by the production of neurotrophic factors
37. GAP JUNCTION PROTEINS AND EPILEPSY GENE EXPRESSION ANALYSIS IN HUMAN DISEASES AND EXPERIMENTAL MODELS
38. OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety
39. Regulation of gap junctional connexin expression in experimental temporal epilepsy
40. Expression of connexins in the rat brain after pilocarpine-induced seizures
41. Poster Session I
42. EXPRESSION OF THE RAT CONNEXIN GENE, RCX39, DURING SKEKETAL MUSCLE DIFFERENTIATION AND REGENERATION
43. Poster Session 4
44. ENGINEERING NEURAL PROGENITOR CELLS FOR BRAIN TUMOR THERAPY
45. CONNEXIN-30 MRNA IS UP-REGULATED IN ASTROCYTES AND IN APOPTOTIC NEURONAL CELLS OF RAT BRAIN FOLLOWING KAINATE-INDUCED SEIZURES
46. Euroglia 2002
47. Connexin-30 mRNA is up-regulated in astrocytes and expressed in apoptotic neuronal cells of rat brain following kainate-induced seizures
48. Expression of neuronal connexins in the genetically epilepsy-prone rat
49. Neuronal connexins in mammalian brain: expression patterns and functional implications
50. Identification of a novel gap junction gene (Cx31.9) expressed in mammalian neurons
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.